Answers are grounded in this paper and cite their sources.
Case report reveals atypical cardiac and skeletal muscle metastases in esophageal cancer, highlighting circulating tumor DNA as a sensitive predictor of recurrence.
Background: Esophageal cancer (EC) comprises 1% of all diagnosed cancers in the USA. It is more common in other parts of the world. If there is distant metastasis, the relative survival rate is 6%. There are no standardized screening methods for EC. Case Presentation: We reported a four-year case of esophageal cancer, a P53-positive mutation with atypical distant metastasis to the cardiac and skeletal muscles. The patient was managed with multimodal therapy, including immunotherapy, which could have been a factor in prolonged survival. Conclusions: Distant metastases are typically seen postmortem, and with prolonged survival, we are able to find such unique metastases antemortem. Despite a history of negative scans, the patient’s ctDNA (circulating tumor DNA) remained positive, which was a better predictor of recurrence in this case. Future research is required to establish cost-effective screening methods and standardized treatments.
No takes yet. Share an insight, caveat, or question.
Hassanain et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: